<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03505970</url>
  </required_header>
  <id_info>
    <org_study_id>SB_BloodMuscle</org_study_id>
    <nct_id>NCT03505970</nct_id>
  </id_info>
  <brief_title>Blood, Muscle and Exercise Responses to Sodium Bicarbonate Supplementation</brief_title>
  <official_title>Blood and Muscle Responses to Sodium Bicarbonate Supplementation and Subsequent Exercise Performance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the changes in activity of transporters of H+
      (monocarboxylate transporters; MCT1, MCT4, NHE) following sodium bicarbonate supplementation
      and subsequent exercise performance. Fifteen healthy men (age 18-35 years) will be invited to
      attend the laboratory on five separate visits to a randomized, double-blind,
      placebo-controlled study. Participants will be supplemented with a 0.3 g/kg dose of sodium
      bicarbonate or placebo (Analytical Pharmacy, Brazil) in opaque gelatin capsules. One hour
      after supplementation they will perform a 1-km time trial and every 10 minutes a blood sample
      will be collected. A muscle biopsy will be taken prior to supplementation, immediately prior
      to exercise, and immediately post-exercise. A questionnaire will be also used to evaluate the
      side-effects associated with sodium bicarbonate supplementation. Muscle and blood samples
      will be analysed for acidity and H+ and muscle samples will be analysed for H+ transporters
      (MCT1, MCT4, NHE).
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2018</start_date>
  <completion_date type="Anticipated">July 2020</completion_date>
  <primary_completion_date type="Anticipated">July 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <intervention_model_description>Double-blind crossover</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>H+ transporter activity</measure>
    <time_frame>5 minutes Post-exercise</time_frame>
    <description>Change in activity of transporters related to H+</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Exercise performance</measure>
    <time_frame>1 hour Post-supplementation</time_frame>
    <description>Change in 1 km cycling time-trial performance</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Sports Nutritional Physiological Phenomena</condition>
  <arm_group>
    <arm_group_label>Sodium bicarbonate</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>0.3 gâˆ™kg-1body mass of sodium bicarbonate</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Individuals will ingest 0.3 g/kg maltodextrin before undergoing exercise</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Sodium bicarbonate</intervention_name>
    <description>Sodium bicarbonate in powder form ingested in gelatine capsules. This leads to an increase bicarbonate concentration in blood, increasing buffering capacity which may lead to improvements in exercise</description>
    <arm_group_label>Sodium bicarbonate</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Maltodextrin</intervention_name>
    <description>Maltodextrin will be used as a placebo as it will not lead to any increases in circulating bicarbonate and, at this dose, will not likely have any physiological effect.</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy males

        Exclusion Criteria:

          -  Smokers

          -  Chronic disease

          -  Prior or current use of steroids

          -  Use of creatine in the last 6 months

          -  Use of beta-alanine in the last 6 months
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>35 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruno Gualano, PhD</last_name>
    <phone>3061-8789</phone>
    <phone_ext>+55</phone_ext>
    <email>gualano@usp.br</email>
  </overall_contact>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 31, 2018</study_first_submitted>
  <study_first_submitted_qc>April 13, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2018</study_first_posted>
  <last_update_submitted>April 21, 2018</last_update_submitted>
  <last_update_submitted_qc>April 21, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 24, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Bruno Gualano</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Physiological Phenomena</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

